Table 2 Least-square means of baseline lipids and apolipoproteins in total plasma according to tertile of PFASa
| Â | Total Cholesterol | Triglycerides | ApoB | ApoE | ApoC-III |
|---|---|---|---|---|---|
PFOS (ng/ml) | |||||
 T1 (< 18.8) | 180.9 ± 8.0 | 126.8 ± 11.6 | 86.6 ± 5.4 | 7.9 ± 0.4 | 13.7 ± 0.9 |
 T2 (18.8–33.1) | 189.3 ± 7.9 | 132.4 ± 11.4 | 90.3 ± 5.3 | 8.2 ± 0.4 | 15.2 ± 0.9 |
 T3 (> 33.1) | 190.7 ± 7.3 | 126.1 ± 10.5 | 94.0 ± 4.9 | 8.4 ± 0.4 | 14.8 ± 0.8 |
 P trend | 0.21 | 0.80 | 0.11 | 0.22 | 0.36 |
PFOA (ng/ml) | |||||
 T1 (< 3.7) | 189.1 ± 7.9 | 111.1 ± 11.2 | 85.7 ± 5.3 | 7.9 ± 0.4 | 13.4 ± 0.9 |
 T2 (3.7–5.6) | 189.3 ± 7.6 | 137.3 ± 10.8 | 91.2 ± 5.0 | 8.2 ± 0.4 | 14.7 ± 0.9 |
 T3 (> 5.6) | 188.4 ± 7.7 | 131.8 ± 10.9 | 95.4 ± 5.1 | 8.4 ± 0.4 | 15.5 ± 0.9 |
 P trend | 0.67 | 0.06 | 0.03 | 0.12 | 0.007 |
PFHxS (ng/ml) | |||||
 T1 (< 1.8) | 181.6 ± 7.8 | 119.4 ± 11.2 | 90.7 ± 5.2 | 8.4 ± 0.4 | 13.9 ± 0.9 |
 T2 (1.8–3.1) | 189.3 ± 7.6 | 133.6 ± 11.0 | 89.7 ± 5.1 | 8.2 ± 0.4 | 14.9 ± 0.9 |
 T3 (> 3.1) | 192.5 ± 7.8 | 130.8 ± 11.2 | 93.0 ± 5.2 | 8.1 ± 0.4 | 15.0 ± 0.9 |
 P trend | 0.15 | 0.37 | 0.55 | 0.39 | 0.28 |
PFNA (ng/ml) | |||||
 T1 (< 1.1) | 185.6 ± 7.7 | 132.9 ± 11.1 | 87.6 ± 5.2 | 7.9 ± 0.4 | 14.4 ± 0.9 |
 T2 (1.1–1.8) | 186.1 ± 7.8 | 128.2 ± 11.2 | 89.8 ± 5.2 | 8.2 ± 0.4 | 14.4 ± 0.9 |
 T3 (> 1.8) | 190.8 ± 7.5 | 123.6 ± 10.8 | 95.0 ± 5.0 | 8.4 ± 0.4 | 15.0 ± 0.9 |
 P trend | 0.39 | 0.35 | 0.08 | 0.20 | 0.38 |
PFDA (ng/ml) | |||||
 T1 (< 0.3) | 183.1 ± 7.9 | 138.9 ± 11.3 | 89.0 ± 5.3 | 7.9 ± 0.4 | 14.5 ± 0.9 |
 T2 (0.3–0.5) | 186.6 ± 7.5 | 119.7 ± 10.7 | 88.2 ± 5.0 | 8.1 ± 0.4 | 14.3 ± 0.9 |
 T3 (> 0.5) | 192.1 ± 7.6 | 129.3 ± 10.8 | 95.6 ± 5.0 | 8.5 ± 0.4 | 15.0 ± 0.9 |
 P trend | 0.17 | 0.32 | 0.13 | 0.12 | 0.52 |